Research Article
Lower Superoxide Dismutase 2 (SOD2) Protein Content in Mononuclear Cells Is Associated with Better Survival in Patients with Hemodialysis Therapy
Table 2
Clinical and biochemical characteristics of CKD patients with hemodialysis therapy. Values are median (interquartile range).
| | Characteristics | Lower than median SOD2 protein | Higher than median SOD2 protein |
| | Age (years) | 66 (58–73) | 66 (56–74) | | Gender (male/female) | 24/16 | 22/18 | | Body mass index (kg/m2) | 24.4 (22.7–28.6) | 24.3 (22.1–27.8) | | Time since initiation of dialysis treatment (days) | 244 (30–481) | 295 (39–1193) | | Hemoglobin (g/dL) | 10.1 (9.3–11.4) | 10.1 (8.6–12.0) | | C-reactive protein (mg/dL) | 2.7 (0.1–6.2) | 2.6 (0.9–6.9) |
|
|
